Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GLUCOCORTICOID DEFICIENCY 3 (disorder)

Known as: GLUCOCORTICOID DEFICIENCY 2, FORMERLY, GCCD3, GLUCOCORTICOID DEFICIENCY 3 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Lung cancer (LC) continues to be the leading cause of cancer-related deaths worldwide and the prognosis remains poor worldwide… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
2019
2019
The FGD3 gene works as a cell migration inhibitor and seems to be a promising indicator of outcome in some human cancers… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
2019
2019
Introduction The literature suggests the involvement of Traditional Health Practitioners (THPs) perspectives in treating diabetes… Expand
  • table 1
  • table 2
2017
2017
BACKGROUND: Premature prelabor rupture of fetal membranes accounts for 30% of all premature births and is associated with… Expand
  • table 1
  • table 3
  • table 4
2015
2015
Recessive skeletal dysplasia, characterized by joint- and/or hip bone-enlargement, was mapped within the critical region for a… Expand
  • figure 4
  • figure 5
  • figure 6
  • table 1
  • table 2
2011
2011
FGD1 encodes a guanine nucleotide exchange factor for Cdc42. Mutations in the FGD1 gene are responsible for an X-linked disorder… Expand
2010
2010
We previously demonstrated that FGD1, the Cdc42 guanine nucleotide exchange factor (GEF) responsible for faciogenital dysplasia… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
2008
2008
We previously demonstrated that FGD1, the Cdc42 guanine nucleotide exchange factor (GEF) responsible for faciogenital dysplasia… Expand
Review
2008
Review
2008
•  Introduction •  Molecular structures of frabin and other related GEFs •  Tissue distribution, subcellular localization and… Expand
Highly Cited
2005
Highly Cited
2005
Follicular thyroid carcinomas (FTC) arise through oncogenic pathways distinct from those involved in the papillary histotype… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4